Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa Licitra

Showing results (251-260 of 311) with videos related to

Pageof 32
Sort By:
Oncotarget|June 1, 2017
Circulating pre-treatment Epstein-Barr virus DNA as prognostic factor in locally-advanced nasopharyngeal cancer in a non-endemic areaSalvatore Alfieri, Nicola Alessandro Iacovelli, Sara Marceglia, et al.
JAMA Otolaryngology-- Head & Neck Surgery|April 10, 2025
Development, Validation, and Valuation of a Head and Neck Cancer-Specific Health Utility Instrument (HNC-8D): A Head and Neck Cancer International Group Collaborative StudyJohn R de Almeida, Jie Su, Abdullah AlShenaiber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 5, 2013
Cabozantinib in progressive medullary thyroid cancerRossella Elisei, Martin J Schlumberger, Stefan P Müller, et al.
The Oncologist|December 21, 2023
Hedgehog Inhibitors Beyond Clinical Complete Response in Basal Cell Carcinoma: Should I Stop or Should I Go?Salvatore Alfieri, Rebecca Romanò, Sara Marceglia, et al.
JCO Precision Oncology|November 5, 2021
Clinical Validity of a Prognostic Gene Expression Cluster-Based Model in Human Papillomavirus-Positive Oropharyngeal CarcinomaStefano Cavalieri, Mara S Serafini, Andrea Carenzo, et al.
Cells|January 11, 2022
Immunotherapy in Nonendemic Nasopharyngeal Carcinoma: Real-World Data from Two Nonendemic RegionsPanagiota Economopoulou, Anastasios Pantazopoulos, Aris Spathis, et al.
European Journal of Dermatology : EJD|January 31, 2019
Assessment of quality of life using Skindex-16 in patients with advanced basal cell carcinoma treated with vismodegib in the STEVIE studyJohan Hansson, Karen Bartley, Thomas Karagiannis, et al.
European Journal of Cancer (Oxford, England : 1990)|July 29, 2025
Longitudinal assessment of plasma EBV-DNA in non-endemic EBV-related nasopharyngeal cancer (NPC): the LEA studySalvatore Alfieri, Rebecca Romanò, Sara Marceglia, et al.
Thyroid : Official Journal of the American Thyroid Association|June 24, 2026
Targeted Therapy-Induced Erythrocytosis in Thyroid Cancers: An Underrecognized Safety Signal from a Retrospective StudySilvia Marchesi, Rebecca Romanò, Andrea Spagnoletti, et al.
The Oncologist|May 31, 2022
Long-term Outcomes with Nivolumab as First-line Treatment in Recurrent or Metastatic Head and Neck Cancer: Subgroup Analysis of CheckMate 141Maura L Gillison, George Blumenschein, Jerome Fayette, et al.
Pageof 32

Showing results (251-260 of 311) with videos related to

Sort By:
Pageof 32
Oncotarget|June 1, 2017
Circulating pre-treatment Epstein-Barr virus DNA as prognostic factor in locally-advanced nasopharyngeal cancer in a non-endemic areaSalvatore Alfieri, Nicola Alessandro Iacovelli, Sara Marceglia, et al.
JAMA Otolaryngology-- Head & Neck Surgery|April 10, 2025
Development, Validation, and Valuation of a Head and Neck Cancer-Specific Health Utility Instrument (HNC-8D): A Head and Neck Cancer International Group Collaborative StudyJohn R de Almeida, Jie Su, Abdullah AlShenaiber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 5, 2013
Cabozantinib in progressive medullary thyroid cancerRossella Elisei, Martin J Schlumberger, Stefan P Müller, et al.
The Oncologist|December 21, 2023
Hedgehog Inhibitors Beyond Clinical Complete Response in Basal Cell Carcinoma: Should I Stop or Should I Go?Salvatore Alfieri, Rebecca Romanò, Sara Marceglia, et al.
JCO Precision Oncology|November 5, 2021
Clinical Validity of a Prognostic Gene Expression Cluster-Based Model in Human Papillomavirus-Positive Oropharyngeal CarcinomaStefano Cavalieri, Mara S Serafini, Andrea Carenzo, et al.
Cells|January 11, 2022
Immunotherapy in Nonendemic Nasopharyngeal Carcinoma: Real-World Data from Two Nonendemic RegionsPanagiota Economopoulou, Anastasios Pantazopoulos, Aris Spathis, et al.
European Journal of Dermatology : EJD|January 31, 2019
Assessment of quality of life using Skindex-16 in patients with advanced basal cell carcinoma treated with vismodegib in the STEVIE studyJohan Hansson, Karen Bartley, Thomas Karagiannis, et al.
European Journal of Cancer (Oxford, England : 1990)|July 29, 2025
Longitudinal assessment of plasma EBV-DNA in non-endemic EBV-related nasopharyngeal cancer (NPC): the LEA studySalvatore Alfieri, Rebecca Romanò, Sara Marceglia, et al.
Thyroid : Official Journal of the American Thyroid Association|June 24, 2026
Targeted Therapy-Induced Erythrocytosis in Thyroid Cancers: An Underrecognized Safety Signal from a Retrospective StudySilvia Marchesi, Rebecca Romanò, Andrea Spagnoletti, et al.
The Oncologist|May 31, 2022
Long-term Outcomes with Nivolumab as First-line Treatment in Recurrent or Metastatic Head and Neck Cancer: Subgroup Analysis of CheckMate 141Maura L Gillison, George Blumenschein, Jerome Fayette, et al.
Pageof 32